Selection and evaluation of the candidate patient for epilepsy surgery

Authors

  • María Del Carmen García Italian Hospital, Buenos Aires, Argentina

DOI:

https://doi.org/10.47924/neurotarget2008415

Keywords:

refractory epilepsy, epilepsy surgery, video-EEG

Abstract

Surgery for epilepsy refractory to medical treatment is a promising therapeutic option. Major determinants of the success of epilepsy surgery are the proper selection and evaluation of the patient. Candidates should have medically intractable epilepsy, defined in most centers as a failure of at least two first-line antiepileptic medications due to the lack of efficacy. The presurgical work-up of patients consists of a Phase I evaluation including magnetic resonance imaging, videoelectroencefalography, neuropsychological testing, psychiatric evaluation and functional imaging techniques. Following the Phase I evaluation, the epilepsy surgery team (consisting of the neurologist/ epileptologist, neurosurgeon, neuroradiologist, neuropsychologist and psychiatrist) reviews all of the data collected, and decides if epilepsy surgery would likely lead to a reduction in seizure frequency without significant side effects. As the results of surgery are best when there is congruence between seizure semiology, irritative zone on interictal EEG, and ictal onset zone, some additional tests are often necessary, such as intracranial electroencephalographic monitoring and cortical functional mapping.

Metrics

Metrics Loading ...

References

Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, Engel J Jr. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46(4):470-2.

Kwan P, Sander JW. The natural history of epilepsy: an epidemiological view. J Neurol Neurosurg Psychiatry. 2004;75(10):1376-81.

Kochen S, Thomson AE, Silva W, García MC; Grupo de Trabajo de Epilepsia de la Sociedad Neurológica Argentina. Guía de Cirugía de la epilepsia. Rev Neurol Arg 2006;31(2):117-22.

Mohanraj R, Brodie MJ. Pharmacological outcomes in newly diagnosed epilepsy. Epilepsy Behav. 2005;6(3):382-7.

Mattson RH, Cramer JA, Collins JF. Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Department of Veterans Affairs Epilepsy Cooperative Studies No. 118 and No. 264 Group. Neurology. 1996;47(1):68-76.

Sillanpää M, Schmidt D. Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Brain. 2006;129 (Pt 3):617-24.

Semah F, Picot MC, Adam C, Broglin D, Arzimanoglou A, Bazin B, Cavalcanti D, Baulac M. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology. 1998;51(5):1256-62.

Lüders HO, Engel J Jr, Munari C. General Principles: In: Engel J, editor. Surgical Treatment of the Epilepsias. 2nd ed. New York: Raven Press; 1993. p. 137-53.

Kanner A, Campos M. Evaluación Prequirúrgica. En: Kanner A, Campos M, editores. Epilepsias: Diagnóstico y Tratamiento. 1a ed. Santiago de Chile: Mediterráneo; 2004. p. 574-96.

Published

2008-05-01

How to Cite

1.
García MDC. Selection and evaluation of the candidate patient for epilepsy surgery. NeuroTarget [Internet]. 2008 May 1 [cited 2025 Feb. 23];3(1):11-7. Available from: https://neurotarget.com/index.php/nt/article/view/415